Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.
The Daily Monitor on MSN18h
US aid freeze sows disruption in HIV, malaria product supply chains
The dismantling of USAID has already had significant impact across the globe, including shuttering HIV clinics, stranding emergency food aid, and halting research. Thank you for reading Nation.Africa ...
The Financial Express7h
Wake up to reality of sleep gummies
Go easy on over-the-counter melatonin supplements — misusing them or taking too many can lead to adverse health effects, say experts.
PipelineReview.com17h
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
REYKJAVIK, Iceland and PARSIPPANY, NJ, USA I1, 2025 I Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: ...